2. Mergers and acquisitions are picking up: So far this year, buyouts have boosted several biotech stocks. Some standouts: ...

Intellia Therapeutics also has fans on Wall Street. The company's current average price target of $32.3 (according to Yahoo!

Dr. George Tidmarsh, the FDA drug regulator who was placed on leave and complained of a “toxic” work environment in an ...

Industry leaders say uncertainty in funding, clinical development and manufacturing is driving companies to embrace digital ...

Aging populations and clearer U.S. drug pricing boost long-term pharma outlook. Leaders like Eli Lilly and Merck lead in ...

According to a new BioPharma Dive analysis, corporate-related funds such as Novo Holdings, Eli Lilly and Sanofi Ventures have ...

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the Stocks to Buy with Exponential Growth Heading into 2026.

Mochida Pharmaceutical Co. Ltd. (4534.TO) Japan Half-Year Ended September 30 GROUP 2025 2024 Revenue Y54.99 bln Y51.10 bln Operating Profit Y4.97 bln Y3.79 bln Pretax Profit Y5.18 bln Y4.08 bln Net ...

Kissei Pharmaceutical Co. Ltd. (4547.TO) Japan Half-Year Ended September 30 GROUP 2025 2024 Revenue Y45.83 bln Y42.47 bln Operating Profit (Y6.84 bln) Y1.78 bln Pretax Profit (Y5.62 bln) Y2.24 bln Net ...

Health Biotech Limited, an Indian pharmaceutical company, successfully showcased its innovative products at CPHI Frankfurt 2025, a notable global pharmaceutical event. The company, celebrated for its ...

Virginia will be home to a workforce training center preparing thousands of people each year for a career in the pharmaceutical industry.